Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Sealantium Medical Belgium from Diepenbeek, company number BE1012599727, closed financial year 2025 with a result of € -7,486 after tax. For that financial year Sealantium Medical Belgium recorded a gross margin of € -7,311 and equity of € 26,210. Compared with financial year 2024, the result moved from € -16,305 to € -7,486. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ 26,210
▼ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -7,486
▲ 54 % less loss than in 2024
Profit after tax over the fiscal year.
€ 4,988
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -23,790.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 670
Supplier invoices still open on the last day of the fiscal year.
€ 1,875
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -16,305 | € -7,311 | ▲ € 8,994 |
| Profit after taxes | € -16,305 | € -7,486 | ▲ € 8,819 |
| Equity | € 33,695 | € 26,210 | ▼ 22% |
| Total debts | € 19,633 | € 29,823 | ▲ 52% |
| Cash | - | € 4,988 | |
| Retained profit | € -16,305 | € -23,790 | ▼ € 7,486 |
| Balance sheet total | € 53,328 | € 56,033 | ▲ 5% |
Key figures of Sealantium Medical Belgium, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Sealantium Medical Belgium?
What happened at Sealantium Medical Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 7,486. Source: NBB ↗
- Bart Van Acker became a director. NBB
- Christopher Charles Lamb became a director. NBB
- New establishment in Diepenbeek. KBO
- Sealantium Medical Ltd. became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 16,305 loss in 2024 to € 7,486 loss in 2025.
A new publication or filing at Sealantium Medical Belgium? We notify you, reason included.
Follow Sealantium Medical BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Sealantium Medical Belgium are Sealantium Medical Ltd., Bart Van Acker and Christopher Charles Lamb. The shares are held by Sealantium Medical Ltd. (100%).
Directors
According to the 2025 annual accounts
Director · represented by Orgad Laub
since 2024
Bart Van Acker
Director
since 2025
Christopher Charles Lamb
Director
since 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Agoralaan Abis
3590 Diepenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →Clinitude
€ 419,430 gross margin · 2025
FOx Biosystems
€ -763,895 gross margin · 2023
Highstar Engineering
€ -41,079 gross margin · 2024
IDEA FAMILY
€ -3,258 gross margin · 2025
BIOKEY
€ -25,987 gross margin · 2025
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1012.599.727
- VAT number
- BE 1012.599.727
- Registered office
- Agoralaan Abis, 3590 Diepenbeek
- Names & denominations
- Sealantium Medical Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 August 2024
- Peppol
- Active · Active since 21 Oct 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied